Tris Pharma eyes approval after pain drug triumphs in second Phase III trial
Tris Pharma has reported another Phase III win with its investigational pain therapy, cebranopadol, and it is now setting up…
Central Nervous System
-
-
Newleos secures $93.5m for neuropsychiatric treatments
Newleos Therapeutics has closed an oversubscribed Series A financing round, raising $93.5m to revolutionise neuropsychiatric disorder treatments with new medicines.…
-
SmartCella gains rights to advance cell therapy research for Parkinson’s
SmartCella has secured exclusive rights to advance research into cell replacement therapies for the treatment of Parkinson's disease (PD). The…
-
Supernus wins FDA approval for Parkinson’s pump on fourth try
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of Parkinson’s disease. Supernus’…
-
USC receives grant for gene therapy targeting glioblastoma
The University of Southern California (USC) has received a $6m grant from the California Institute for Regenerative Medicine (CIRM) to…
-
Eisai and Biogen’s Leqembi sBLA set for Alzheimer’s maintenance dosing
The US Food and Drug Administration has approved the supplemental biologics licence application (sBLA) of Eisai and Biogen's Leqembi (lecanemab-irmb)…
-
Acadia submits MAA to EMA for Rett syndrome therapy
Acadia Pharmaceuticals has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for trofinetide, aimed at treating…
-
Eisai and Biogen’s subcutaneous Leqembi set for FDA review
Eisai and Biogen are one step away from deploying a more convenient version of their jointly developed Alzheimer’s treatment Leqembi…
-
Neumora shares sink following Phase III flop in MDD
Neumora Therapeutics saw a drop of more than 80% in its share price following the announcement of a Phase III…
-
Astellas and Sangamo sign capsid deal for neurological diseases
Astellas Pharma and Sangamo Therapeutics have signed a licence agreement for a neurotropic adeno-associated virus (AAV) capsid, STAC-BBB, aimed at…
